Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn how cell-free DNA analysis combined with artificial intelligence technology enables early cancer detection and treatment response prediction through liquid biopsy methods in this invited speaker presentation. Explore the cutting-edge applications of circulating tumor DNA in non-invasive cancer screening and monitoring, understanding how AI algorithms enhance the sensitivity and specificity of liquid biopsy approaches. Discover the clinical implications of cell-free DNA testing for early-stage cancer identification, examine the technological advances that make liquid biopsies viable alternatives to traditional tissue-based diagnostics, and gain insights into how these innovations are transforming cancer care by enabling earlier intervention and personalized treatment strategies. Understand the molecular mechanisms underlying cell-free DNA release, the computational methods used to analyze circulating genetic material, and the potential for liquid biopsies to revolutionize cancer detection protocols in clinical practice.
